¿Qué es el aclaramiento esofágico? ¿Cuáles son los factores agresivos? ¿Cuál es el rol de la Hernia del Hiato? ¿Qué factores de riesgo/protección se asocian. dr marugán tema reflujo gastroesofágico el reflujo es una cuestión de cantidad, todos tenemos reflujo pero cuando ese paso de contenido gástrico es mayor de . mediante pH-metría ambulatoria de 24 horas y un estudio isotópico con radionúclidos para determinar el aclaramiento esofágico de líquidos a largo plazo.
|Published (Last):||9 July 2015|
|PDF File Size:||18.25 Mb|
|ePub File Size:||4.44 Mb|
|Price:||Free* [*Free Regsitration Required]|
A prospective randomized trial of Angelchik prosthesis versus Nissen fundoplication. For these items you should use the filters and not add them to your search terms in the text field. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
Subscribe to our Newsletter. Health-related quality of life. Lancet,pp.
Cirugía General MIP Flashcards
Currently receiving any anti-tumor treatments, or less than 14 days prior to enrollment since ending anti-tumor treatment. The Angelchik prosthesis behaves as a fundoplication. Patient-reported outcomes assessment will be done at baseline and at every radiological assessment thereafter, including radiological assessments to confirm tumour progression when symptoms of aclzramiento progression occur.
A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia.
EU Clinical Trials Register. Methods Twenty-six patients who underwent implantation of an Angelchik xclaramiento between March and June were prospectively followed-up months, median by means of a questionnaire, barium contrast, endoscopy, and manometric studies.
Cir Esp, 42pp. To evaluate the effectiveness of the Angelchik prosthesis in controlling gastroesophageal reflux and its effect on esophageal function in the long term.
Pneumonia AND sponsor name. Outcomes of laparoscopic antireflux procedures.
A new concept in the surgical treatment of gastroesophageal reflux. Br J Aclaarmiento, 71pp. Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.
Prospective study of the Angelchik antireflux prosthesis. New complications associated with the Angelchik prosthesis.
Proyecto Quimica by Victoria Becerra Barraza on Prezi
Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis. J Coll Surg, 35pp. Conclusions The Angelchik prosthesis produces a sustained long-term improvement in LES function with few adverse effects on esophageal body dynamics or the upper esophageal sphincter. Of 15 patients who underwent pH-metry, only one presented reflux.
Print Send to a friend Export reference Mendeley Statistics. Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. Long-term results of the Angelchik prosthesis for gastroesophageal reflux. An experimental study in the dog.
Br J Surg, 76pp.
MANSONTELOSIS by diana minaya on Prezi
Clinical trials The European Union Clinical Trials Register allows you to aclsramiento for protocol and results information on: World J Surg, 24pp. De Vos Shoop, J. Ann R Coll Surg Engl, 75pp. The Angelchik prosthesis produces a sustained long-term improvement in LES function with few adverse effects on esophageal body dynamics or the upper esophageal sphincter.
Gut, 40pp. Review by the Competent Authority or Ethics Committee in the country concerned. Johns Wort and other herbal supplements known to induce CYP3A4 less than 14 days prior to study day 1. Antireflux mechanism of Nissen fundoplication. How to search [pdf]. Randomized prospective trial of the Angelchik antireflux prosthesis. February Pages Date on which this record was first entered in the EudraCT database:.
Scand J Gastroenterol, 27pp.